A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

被引:48
作者
Cochran, Siska [1 ]
Li, Cai Ping [1 ]
Ferro, Vito [1 ]
机构
[1] Progen Pharmaceut Ltd, Drug Design Grp, Darra, Qld, Australia
关键词
Heparan sulfate-binding proteins; heparin; solution affinity assay; surface plasmon resonance; FIBROBLAST-GROWTH-FACTOR; GLYCOSAMINOGLYCAN OLIGOSACCHARIDES; SUCROSE OCTASULFATE; BIOLOGICAL-ACTIVITY; CELL-PROLIFERATION; LIGAND-BINDING; MODEL; ANGIOGENESIS; INHIBITORS; DOMAIN;
D O I
10.1007/s10719-008-9210-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A surface plasmon resonance-based solution affinity assay is described for measuring the K (d) of binding of heparin/heparan sulfate-binding proteins with a variety of ligands. The assay involves the passage of a pre-equilibrated solution of protein and ligand over a sensor chip onto which heparin has been immobilised. Heparin sensor chips prepared by four different methods, including biotin-streptavidin affinity capture and direct covalent attachment to the chip surface, were successfully used in the assay and gave similar K (d) values. The assay is applicable to a wide variety of heparin/HS-binding proteins of diverse structure and function (e.g., FGF-1, FGF-2, VEGF, IL-8, MCP-2, ATIII, PF4) and to ligands of varying molecular weight and degree of sulfation (e.g., heparin, PI-88, sucrose octasulfate, naphthalene trisulfonate) and is thus well suited for the rapid screening of ligands in drug discovery applications.
引用
收藏
页码:577 / 587
页数:11
相关论文
共 59 条
[1]   DENSIMETRIC DETERMINATION OF EQUILIBRIUM BINDING OF SUCROSE OCTASULFATE WITH BASIC FIBROBLAST GROWTH-FACTOR [J].
ARAKAWA, T ;
WEN, J ;
PHILO, JS .
JOURNAL OF PROTEIN CHEMISTRY, 1993, 12 (06) :689-693
[2]   Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library [J].
Ashikari-Hada, S ;
Habuchi, H ;
Kariya, Y ;
Itoh, N ;
Reddi, AH ;
Kimata, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12346-12354
[3]   Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties [J].
Avci, FY ;
Karst, NA ;
Linhardt, RJ .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (28) :2323-2335
[4]   Heparan sulphate proteoglycans fine-tune mammalian physiology [J].
Bishop, Joseph R. ;
Schuksz, Manuela ;
Esko, Jeffrey D. .
NATURE, 2007, 446 (7139) :1030-1037
[5]   Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors [J].
Blaszczyk, J ;
Van Coillie, E ;
Proost, P ;
Van Damme, J ;
Opdenakker, G ;
Bujacz, GD ;
Wang, JM ;
Ji, XH .
BIOCHEMISTRY, 2000, 39 (46) :14075-14081
[6]   Validation of molecular docking calculations involving FGF-1 and FGF-2 [J].
Bytheway, I ;
Cochran, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1683-1693
[7]   Interaction of heparin with annexin V [J].
Capila, I ;
VanderNoot, VA ;
Mealy, TR ;
Seaton, BA ;
Linhardt, RJ .
FEBS LETTERS, 1999, 446 (2-3) :327-330
[8]  
Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
[9]   Structure and biological interactions of heparin and heparan sulfate [J].
Casu, B ;
Lindahl, U .
ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 57, 2001, 57 :159-206
[10]   An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2 [J].
Cochran, S ;
Li, CP ;
Bytheway, I .
CHEMBIOCHEM, 2005, 6 (10) :1882-1890